{
  "trial_id": "NCT00341250",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "unknown"
    },
    {
      "criterion": "Residence in Doneguebougou, Mali or Bancoumana",
      "label": "not_met"
    },
    {
      "criterion": "Good general health",
      "label": "met"
    },
    {
      "criterion": "Available for the duration of the trial (52 weeks)",
      "label": "met"
    },
    {
      "criterion": "Willingness to participate in the study",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Evidence of clinically significant neurologic, cardiac, pulmonary, hepatic, rheumatologic, autoimmune, chronic infectious or renal disease",
      "label": "unknown"
    },
    {
      "criterion": "Behavioral, cognitive, or psychiatric disease",
      "label": "unknown"
    },
    {
      "criterion": "Laboratory evidence of liver disease (ALT greater than 1.25 times the upper limit of normal)",
      "label": "not_met"
    },
    {
      "criterion": "Laboratory evidence of renal disease (serum creatinine greater than the upper limit of normal, or more than trace protein or blood on urine dipstick testing)",
      "label": "not_met"
    }
  ],
  "notes": "The patient is a healthy woman with no underlying diseases. She has had her flu shot this year and exercises regularly.",
  "_meta": {
    "topic_id": "33",
    "trial_id": "NCT00341250",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}